Updated interim results with an additional ~12 weeks of follow-up since prior update at ASCO-GI in January 2026 and ~25 weeks since ESMO in October 2025Safety update presented on all 64 patients who ...
Roche has shared details of fatalities in its phase 3 relapsing multiple sclerosis (RMS) trials, revealing that deaths from ...
Construction on the new Wasatch County administration building is underway. Next up: a three-phased Wasatch County jail upgrade.
Indian expat students make history as multiple students score 100%, schools record 100% pass rate despite conflict ...
WA Gold has unveiled a robust economic profile for initial mining at its Abercromby gold project in WA with a scoping study ...
Safety featured universal TEAEs and 92% grade ≥3 events; anemia (39.5%) predominated, discontinuations were frequent, and ...
BBO-11818 is currently being evaluated in the Phase 1 KONQUER-101 trial in subjects with locally advanced unresectable or ...
PORT-AU-PRINCE, April 16 (Reuters) - Nearly 6 million people in Haiti are expected to face acute food insecurity in the ...
Environmentalists and state lawmakers debate whether the funds should be spent on school upgrades or return it to ...
Your talk at Extech 1 is focused on the characterization of recycled polyolefines as future food contact materials. What is ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License ...
DELTA 3 enrolled 560 delgocitinib-treated completers from DELTA 1/2; 472 were week-52 completers after 16 weeks BID induction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results